<DOC>
	<DOCNO>NCT01157507</DOCNO>
	<brief_summary>Previous clinical observation show Botulinum A toxin ( BoNT/A ) also antinociceptive effect control neuropathic pain . In urologic field , recent vitro vivo study demonstrate neurotoxin able inhibit release several neurotransmitter bladder afferent fiber urothelium . These neurotrasmitters SP , CGRP , ATP , NGF Prostaglandins involve neurogenic inflammation . Thus , reasonable hypothesize patient affect painful bladder syndrome ( PBS ) could benefit BoNT/A intravesically administer . The aim study investigate clinical urodynamic effect intravesical treatment BoNT/A patient affect PBS associate increase urinary frequency , refractory conventional treatment . This treatment compare bladder distention , consider conventional therapy .</brief_summary>
	<brief_title>Botulinum A Toxin Treatment Patients With Painful Bladder Syndrome</brief_title>
	<detailed_description>Patients refractory PBS prospectively enrol study . Baseline evaluation : Clinical evaluation visual analog scale ( VAS ) pain quantification ; QoL assessment standardize questionnaire , HAM-A HAM-D scale evaluation anxiety depression ; void diary record diurnal nocturnal urinary frequency ; urodynamic evaluation , 1 month commence study . Treatment : According computerized randomization , patient receive : A ) one single injection BoNT/A , 100 U dilute 10 ml normal saline bladder , cystoscopic guidance , local anesthesia ; B ) one single bladder overdistension local anesthesia . C ) one single injection placebo ( NACL 0.9 % 10 ml ) local anesthesia . Follow : clinical evaluation ( VAS , HAM-A HAM-D , QOL assessment , void diary ) urodynamics three month treatment .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<criteria>refractory bladder pain , urgencyfrequency syndrome , sterile urine neurological disease pregnancy concomitant use aminoglycosides anticoagulant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Botulinum A toxin</keyword>
	<keyword>Painful Bladder Syndrome ( PBS )</keyword>
	<keyword>Bladder overdistention</keyword>
</DOC>